EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Hypertensive Disorders of Pregnancy and the Cardiovascular System: Causes, Consequences, Therapy, and Prevention

Ahmet A Baschat iD, Kristin Darwin iD, Arthur J Vaught

American Journal of Perinatology · 2024-07 · 41 (10) · 1298-1310

DOI: 10.1055/a-2051-2127 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Perinatology, online erschienen am 10.04.2023. Verfasst von Ahmet A Baschat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Center for Fetal Therapy, Baltimore, Maryland. Hauptthemen laut MEDLINE: Hypertension, Pregnancy-Induced. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 156 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertensive disorders of pregnancy continue to be significant contributors to adverse perinatal outcome and maternal mortality, as well as inducing life-long cardiovascular health impacts that are proportional to the severity and frequency of pregnancy complications. The placenta is the interface between the mother and fetus and its failure to undergo vascular maturation in tandem with maternal cardiovascular adaptation by the end of the first trimester predisposes to hypertensive disorders and fetal growth restriction. While primary failure of trophoblastic invasion with incomplete maternal spiral artery remodeling has been considered central to the pathogenesis of preeclampsia, cardiovascular risk factors associated with abnormal first trimester maternal blood pressure and cardiovascular adaptation produce identical placental pathology leading to hypertensive pregnancy disorders. Outside pregnancy blood pressure treatment thresholds are identified with the goal to prevent immediate risks from severe hypertension >160/100 mm Hg and long-term health impacts that arise from elevated blood pressures as low as 120/80 mm Hg. Until recently, the trend for less aggressive blood pressure management during pregnancy was driven by fear of inducing placental malperfusion without a clear clinical benefit. However, placental perfusion is not dependent on maternal perfusion pressure during the first trimester and risk-appropriate blood pressure normalization may provide the opportunity to protect from the placental maldevelopment that predisposes to hypertensive disorders of pregnancy. Recent randomized trials set the stage for more aggressive risk-appropriate blood pressure management that may offer a greater potential for prevention for hypertensive disorders of pregnancy. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, Pregnancy-InducedHumansPregnancyFemalePlacentaPre-EclampsiaAntihypertensive AgentsBlood PressurePregnancy Trimester, FirstRisk Factors

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Johns Hopkins Center for Fetal Therapy, Baltimore, Maryland.
  • Division of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

ORCID-Profile: Ahmet A Baschat, Kristin Darwin

Zitieren

APA

Baschat, A. A., Darwin, K., & Vaught, A. J. (2024). Hypertensive Disorders of Pregnancy and the Cardiovascular System: Causes, Consequences, Therapy, and Prevention. American Journal of Perinatology, 41(10), 1298-1310. https://doi.org/10.1055/a-2051-2127

Vancouver

Baschat AA, Darwin K, Vaught AJ. Hypertensive Disorders of Pregnancy and the Cardiovascular System: Causes, Consequences, Therapy, and Prevention. American Journal of Perinatology. 2024;41(10):1298-1310. doi:10.1055/a-2051-2127

BibTeX
@article{Baschat2024,
  author = {Baschat, Ahmet A and Darwin, Kristin and Vaught, Arthur J},
  title = {Hypertensive Disorders of Pregnancy and the Cardiovascular System: Causes, Consequences, Therapy, and Prevention},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {10},
  pages = {1298--1310},
  doi = {10.1055/a-2051-2127}
}
Kostenlos starten →